The stock's overall trend over the past six months has been volatile but negative, with a 14.0% decline from the start of the period. The price peaked near $366 in late January 2026 before a sharp correction.

Short-term performance shows significant weakness, with the stock down 11.5% over the past month, underperforming the S&P 500's 5.25% decline. Over the past three months, the stock is down 1.3%, but this still represents a 3.3% outperformance relative to the broader market.

The current price of $275.18 sits approximately 24.9% below its 52-week high of $366.50 and 67.8% above its 52-week low of $164.01. This positions the stock in the upper half of its yearly range, though well off recent highs.

Revenue growth remains strong, with Q4 2025 revenue of $4.26 billion representing a 13.2% year-over-year increase. However, profitability has shown sequential pressure; the Q4 net margin of 17.7% declined from 30.7% in Q3 2025, indicating potential cost or seasonal headwinds.

Financial health is a concern, with a high debt-to-equity ratio of 2.26 and a weak current ratio of 0.18, suggesting significant leverage and limited short-term liquidity. Positively, the company generated $1.24 billion in trailing twelve-month free cash flow, providing some operational flexibility.

Operational efficiency metrics are mixed. Return on Equity is exceptionally high at 42.6%, but this is largely driven by the high financial leverage. Return on Assets is a more modest 7.8%, reflecting the capital-intensive nature of the business.